Woodline Partners LP
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1784547
San Francisco, CA
Position in PBH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,236,601
+$9,354,440 QoQ
Shares Held
273,943
+187.0% QoQ
Ownership
0.578%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $139,051,923 across 13 Drug Manufacturers - Specialty & Generic names. PBH ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,163,863 | $35,055,553 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
448,996 | $23,208,603 | |
| 3 | ALKS |
Alkermes plc.
|
558,567 | $19,750,929 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
273,943 | $16,236,601 | |
| 5 | VTRS |
Viatris Inc
|
1,167,948 | $15,778,977 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
845,800 | $11,756,620 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
170,699 | $4,212,851 | |
| 8 | LQDA |
Liquidia Corp
|
100,160 | $3,780,038 |
All Filings in PBH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,236,601 | 273,943 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $6,882,161 | 95,453 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,685,104 | 68,048 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $2,278,189 | 38,334 | Shares | Sole | 2023-08-14 | |
| 2021-12-31 | $8,372,004 | 138,038 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,730,641 | 66,488 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||